As 2025 comes to a close, CMS signals are becoming clearer across rural health, specialty care, chronic care, prevention, and accountable care. In this end-of-year episode, Coral Founder Meg Koepke is joined by Maria Alexander, Kate Freeman, and Trevor Abeyta to unpack what the latest federal models reveal about where policy and accountability are heading in 2026 and beyond. They discuss what RHTP signals about rural transformation, how ASM expands mandatory accountability into specialty care, what ACCESS shows about the future of digital chronic care, how LEAD reflects a shift toward longer-term accountable care, and why MAHA ELEVATE represents a new bet on prevention. Together, they reflect on what this mix of mandatory and voluntary models and fast experimentation with long horizons means for organizations preparing for the next phase of health care transformation.

The Rural Health Transformation Program represents a $50 billion investment in the future of rural health care. In this episode, Coral Directors Kate Freeman and Trevor Abeyta are joined by Caitlin Westerson, Senior Director for State Policy and Advocacy at United States of Care, to explore what this program means for states, providers, and communities. Together, they unpack the opportunities and challenges in applying for funding, the role of value-based care in building sustainable models, and how states can align stakeholders to create lasting change in rural health systems.

GLP-1 medications like Ozempic and Wegovy have quickly moved from niche treatments to the center of high-stakes conversations across payers about cost, access, and coverage. In this episode, Coral Partner Alison Falb talks with Laura Rudder Huff, Vice President at Gallagher Research & Insights, about how the rise of GLP-1s is shaping employer benefit strategies, equity considerations, and policy debates.